Australia markets open in 6 hours 24 minutes

Zealand Pharma A/S (ZLDPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
46.920.00 (0.00%)
As of 03:59PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.75B
Enterprise value 2.54B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)50.90
Price/book (mrq)10.25
Enterprise value/revenue 7.38
Enterprise value/EBITDA -3.51

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 366.98%
S&P500 52-week change 311.64%
52-week high 348.49
52-week low 327.40
50-day moving average 343.48
200-day moving average 337.48

Share statistics

Avg vol (3-month) 3120
Avg vol (10-day) 3210
Shares outstanding 558.33M
Implied shares outstanding 658.4M
Float 844.91M
% held by insiders 10.18%
% held by institutions 156.80%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin -227.51%
Operating margin (ttm)15.30%

Management effectiveness

Return on assets (ttm)-21.22%
Return on equity (ttm)-69.63%

Income statement

Revenue (ttm)343.48M
Revenue per share (ttm)6.27
Quarterly revenue growth (yoy)576.00%
Gross profit (ttm)103.99M
EBITDA -492.43M
Net income avi to common (ttm)-760.05M
Diluted EPS (ttm)-2.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.58B
Total cash per share (mrq)27.14
Total debt (mrq)116.06M
Total debt/equity (mrq)6.39%
Current ratio (mrq)7.63
Book value per share (mrq)31.16

Cash flow statement

Operating cash flow (ttm)-757.47M
Levered free cash flow (ttm)-95.14M